Skip to Main Content

Author Details

James M Reuben
The University of Texas MD Anderson Cancer Center
1978
250
67
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36762061Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.Transl Lung Cancer Res2023
36900406Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients.Cancers (Basel)2023
34331589Anamorelin combined with physical activity, and nutritional counseling for cancer-related fatigue: a preliminary study.Support Care Cancer2022
35379811Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling.Nat Commun2022
36525493EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.Sci Adv2022
36358657A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System.Cancers (Basel)2022
35278078Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.Oncologist2022
34250544Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment.J Natl Cancer Inst2022
34170017Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities.Prostate2021
33902690Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.Genome Med2021
34965510Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.J Natl Compr Canc Netw2021
34241740Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.Breast Cancer Res Treat2021
32434589Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.Breast Cancer Res2020
31924241A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.Breast Cancer Res2020
31849202Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer.Cancer Med2020
33209617Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients.Transl Lung Cancer Res2020
33095819Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization.PLoS One2020
33148307Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy.J Transl Med2020
32214335EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.PLoS One2020
31054033Elevated serum levels of sialyl Lewis X (sLe<sup>X</sup>) and inflammatory mediators in patients with breast cancer.Breast Cancer Res Treat2019
31751384Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.PLoS One2019
31452692Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.Ther Adv Med Oncol2019
31364034Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.Curr Hematol Malig Rep2019
30952723Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.Anticancer Res2019
31043414Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer.Cancer Immunol Res2019
30771872The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.Crit Rev Oncol Hematol2019
28589573In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines.Vet Comp Oncol2018
29858753Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.Breast Cancer Res Treat2018
29879283Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer.JAMA Oncol2018
30248155Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.PLoS One2018
30312311Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.PLoS One2018
29748602Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key.Nat Rev Cancer2018
29467936Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer.Oncotarget2018
29487226Emerging Perspectives on mTOR Inhibitor-Associated Pneumonitis in Breast Cancer.Oncologist2018
29485045Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.Int J Radiat Oncol Biol Phys2018
29703913Inflammatory breast cancer biology: the tumour microenvironment is key.Nat Rev Cancer2018
27374101Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.Oncotarget2017
28477745Circulating tumor cells and coagulation-Minireview.Crit Rev Oncol Hematol2017
28243898Identification of frequent somatic mutations in inflammatory breast cancer.Breast Cancer Res Treat2017
284733154-1BB-Enhanced Expansion of CD8<sup>+</sup> TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8<sup>+</sup> T Cells.Cancer Immunol Res2017
28417335Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.Breast Cancer Res Treat2017
28368261Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.Lancet Oncol2017
29667990Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10<sup>th</sup> Anniversary Conference.J Cancer2017
28957377Androgen receptor expression on circulating tumor cells in metastatic breast cancer.PLoS One2017
28978083EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.Oncotarget2017
28539464Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.Clin Cancer Res2017
28831670Thrombocytosis as a prognostic factor in inflammatory breast cancer.Breast Cancer Res Treat2017
28717401Novel therapeutic strategies in the treatment of triple-negative breast cancer.Ther Adv Med Oncol2017
28843370A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.Int J Radiat Oncol Biol Phys2017
28679765Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.Clin Cancer Res2017
  • 1 - 50 of 250

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 1
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 3
Danh Tran-Thanh
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
Mark E Smolkin
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
Marcin Moniuszko
Medical University of Bialystok
Career Start Year 2001
Number of shared co-authors 0
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 5
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 0
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 0
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 2
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 0
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 5
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 1
Thomas Decker
University of Vienna
Career Start Year 1985
Number of shared co-authors 1
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 4
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
Wolfgang Holter
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Stephen E Kurtz
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1979
Number of shared co-authors 0
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 1
Peter J Selby
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 0
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 2
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 2

Collaborators

Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 67
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 60
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers 40
Bora Lim
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Lajos Pusztai
Co-authored papers 9
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers 8
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Eleni Andreopoulou
New York Presbyterian Hospital
Co-authored papers 8
Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
Co-authored papers 7
Thomas A Buchholz
Co-authored papers 7
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 6
Yu Shen
Co-authored papers 6
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers 5
William F Symmans
Co-authored papers 5
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Timothy M Kuzel
548377Rush University Medical Center
Co-authored papers 3
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jorge Cortes
Georgia Cancer Center
Co-authored papers 3
Sanford A Stass
University of Maryland School of Medicine
Co-authored papers 3
Daniel Birnbaum
Co-authored papers 3
Wei Yang
Co-authored papers 3
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 2
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers 2
Michael T Lewis
Baylor College of Medicine
Co-authored papers 2
Mark J Ratain
University of Chicago
Co-authored papers 2
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 2
Matthew J Ellis
Co-authored papers 2
Arvind Rao
University of Michigan-Ann Arbor
Co-authored papers 2
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Release 1.2